ABT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This is the expense the company spent on research and development. Abbott Laboratories's research and development for the three months ended in Jun. 2014 was $335 Mil. Its research and development for the trailing twelve months (TTM) ended in Jun. 2014 was $1,465 Mil.
This is the expense the company spent on research and development.
Abbott Laboratories Research & Development for the trailing twelve months (TTM) ended in Jun. 2014 was 356.877 (Sep. 2013 ) + 386.243 (Dec. 2013 ) + 387 (Mar. 2014 ) + 335 (Jun. 2014 ) = $1,465 Mil.
If competitive advantage is created by a patent or tech advantage, at some point it will disappear.
High R&D usually dictates high SG&A which threatens the competitive advantage.
Abbott Laboratories Annual Data
|Research & Development||1,697||1,821||2,255||2,506||2,689||2,744||4,038||4,129||4,322||1,452|
Abbott Laboratories Quarterly Data
|Research & Development||1,006||1,011||1,164||1,141||346||363||357||386||387||335|